FDA approval action for a generic tofacitinib citrate formulation; does not report clinical trial outcomes or comparative efficacy data.
Reported
Approval status date2026-06-03
Approved strength 15 mg base
Approved strength 210 mg base
Loading
Drug or technology
1 development in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
FDA approval action for a generic tofacitinib citrate formulation; does not report clinical trial outcomes or comparative efficacy data.